Caladrius Biosciences
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Caladrius Biosciences generated cash of -$22,245,000, which is less than the previous year. Cash used in financing activities reached the amount of $85,276,000 last year. Net change in cash is therefore $8,135,000.
Cash Flow
| 2012 | -13.85M | 6.08M | 8.74M |
|---|---|---|---|
| 2013 | -27.10M | -2.69M | 62.18M |
| 2014 | -46.89M | -10.73M | 30.67M |
| 2015 | -39.25M | 3.79M | 36.60M |
| 2016 | -23.66M | -2.84M | 20.90M |
| 2017 | -20.87M | 41.27M | -931.76K |
| 2018 | -19.98M | -4.70M | 824K |
| 2019 | -18.88M | 21.43M | 1.18M |
| 2020 | -8.82M | -7.27M | 18.58M |
| 2021 | -22.24M | -54.89M | 85.27M |
CLBS Cash Flow Statement (2012 – 2021)
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 16.51M | 14.03M | 10.29M | 34.16M | 14.70M | 20.31M | 19.17M | 46.13M | 13.73M | 12.74M |
Operating activities | ||||||||||
Net income | -27.46M | -8.15M | -19.36M | -16.16M | 22.97M | -32.65M | -80.88M | -54.87M | -38.98M | -53.76M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 55K | 63K | 65K | 225K | 372.00K | 2.74M | 2.68M | 2.18M | 1.60M | 1.55M |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.83M | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.83M | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | -95.68K | -325.62K | 545.17K | -1.19M | -573.00K | -554.88K |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -157.19K | -465.28K |
Accounts payable | 1.25M | -2.83M | -1.86M | -5.90M | 5.66M | -48.69K | 79.25K | 469.82K | 2.91M | 1.67M |
Cash generated by operating activities | -22.24M | -8.82M | -18.88M | -19.98M | -20.87M | -23.66M | -39.25M | -46.89M | -27.10M | -13.85M |
Investing activities | ||||||||||
Purchases Of Investments | -179.77M | -34.79M | -32.93M | -69.69M | -60.15M | 0 | -6.08M | -8.04M | 0 | 0 |
Investments In Property Plant And Equipment | -60K | -20K | 0 | -134K | -135.28K | -2.84M | -3.18M | -3.65M | -2.69M | -531.31K |
Acquisitions Net | 0 | 0 | 0 | 0 | 67.87M | 0 | 3.18B | 50.89K | 0 | 12.28M |
Cash generated by investing activities | -54.89M | -7.27M | 21.43M | -4.70M | 41.27M | -2.84M | 3.79M | -10.73M | -2.69M | 6.08M |
Financing activities | ||||||||||
Common Stock Issued | 85.5M | 18.72M | 1.31M | 1.03M | 5.70M | 11.56M | 36.47M | 16.71M | 58.73M | 16.42M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -327.74K |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -5.39M |
Repayments of term debt | 0 | 0 | 0 | -159K | 0 | -10.96M | 0 | -4.33M | -704.92K | -637.06K |
Cash used in financing activities | 85.27M | 18.58M | 1.18M | 824K | -931.76K | 20.90M | 36.60M | 30.67M | 62.18M | 8.74M |
Net Change In Cash | 8.13M | 2.48M | 3.73M | -23.86M | 19.46M | -5.61M | 1.14M | -26.95M | 32.39M | 992.02K |
Cash at end of period | 24.64M | 16.51M | 14.03M | 10.29M | 34.16M | 14.70M | 20.31M | 19.17M | 46.13M | 13.73M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |